The Cardiovascular System Medicine Sales in Finland exhibited a peak in 2016 with €210.1 million, followed by a consistent decline to €119.8 million in 2023. In 2021, sales stood at €130.7 million, showing a declining year-on-year variation of -5.5%. Since 2018, the Compound Annual Growth Rate (CAGR) has been negative, demonstrating a contraction in the market. This decline became more pronounced with a CAGR of -7.02% during the last five years (2018-2023).
Between 2024 and 2028, sales are forecasted to continuously trend downward, with a forecasted 5-year CAGR of -1.64%, resulting in an estimated market size of €106.7 million by 2028.
Future trends to watch for:
- Impact of new medical technologies and treatments for cardiovascular diseases
- Potential demographic changes, including aging population
- Health policy changes and their effects on drug prescription practices
